Patents by Inventor Cornelis P. Hollenberg

Cornelis P. Hollenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6602682
    Abstract: Kluyveromyces hosts and DNA expression cassettes for use in Kluyveromyces are provided for transcription of endogenous and/or exogenous DNA, and production of peptides, for enhancing production of an endogenous product, or producing an exogenous product. The Kluyveromyces hosts find particular use for secretion of a desired peptide product, where signal sequences may be native to the peptide or provided from endogenous or exogenous signal sequences, including synthetic sequences, functional in Kluyveromyces. A transformation procedure is provided for efficiently transforming Kluyveromyces.
    Type: Grant
    Filed: May 29, 1991
    Date of Patent: August 5, 2003
    Assignee: DSM N.V.
    Inventors: Johan Abel Van Den Berg, Albert Johannes Joseph Van Ooyen, Krijn Rietveld, Cornelis P. Hollenberg, Sunil Das, Albert De Leeuw
  • Patent number: 6103519
    Abstract: A composite particle comprising at least two polypeptides corresponding to all or part of a protein having the biological activity of one of the hepatitis B surface antigens, wherein the particle presents at least two antigenic determinants provided by the S-protein, preS2-protein or preS1-protein, said particle optionally further comprising host specific lipids. The invention also provides a modified hepatitis B surface antigen L protein which may be used alone or incorporated into such composite particles.A particular embodiment of the modified L protein (L*) comprises residues 12-52 followed by residues 133-145 followed by residues 175-400 of the L protein and a particular embodiment of a composite particle has the form (L*, S) where S is the S-protein of HBsAg.Improved hepatitis B vaccines may be prepared following expression of the above immunogens, especially in yeasts such as S. cerevisiae and Hansenula polymorpha.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: August 15, 2000
    Assignee: SmithKline Biologicals, S.A.
    Inventors: Martin Comberbach, Nigel Harford, Teresa Cabezon, Apolonia Rutgers, Pierre Voet, Eric Jacobs, Cornelis P. Hollenberg, Zbigniew A. Janowicz, Armin J. Merckelbach
  • Patent number: 5741672
    Abstract: The structural genes and their regulatory DNA sequences of an alcohol oxidase (MOX) and a dihydroxyacetone synthase (DHAS) of Hansenula polymorpha have been isolated and the nucleotide sequences determined. The invention relates to the use of the MOX gene, as well as the use of the regulatory DNA sequences of MOX and/or DAS in combination with the MOX gene, optionally after modification thereof, or other oxidase genes, or other genes, to produce engineered microorganisms, 0in particular yeasts. Said engineered microorganisms can produce oxidases or other enzymes in yields that allow industrial application on a large scale. Moreover, said engineered microorganisms can produce oxidases having improved properties with respect to their application in oxidation reactions and/or in bleaching and detergent products.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 21, 1998
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Adrianus M. Ledeboer, Jan Maat, Cornelis T. Verrips, Christiaan Visser, Zbigniew A. Janowicz, Cornelis P. Hollenberg
  • Patent number: 5561071
    Abstract: The invention relates to construction of specific molecular microcircuits by the use of double and single stranded nucleic acids and specific DNA-binding proteins.
    Type: Grant
    Filed: September 25, 1995
    Date of Patent: October 1, 1996
    Inventors: Cornelis P. Hollenberg, Ernesto di Mauro
  • Patent number: 5240838
    Abstract: The structural genes and their regulatory DNA sequences of an alcohol oxidase (MOX) and a dihydroxyacetone synthase (DHAS) of Hansenula polymorpha have been isolated and the nucleotide sequences determined. The invention relates to the use of the MOX gene, as well as the use of the regulatory DNA sequences of MOX and/or DAS in combination with the MOX gene, optionally after modification thereof, or other oxidase genes, or other genes, to produce engineered microorganisms, in particular yeasts. Said engineered microorganisms can produce oxidases or other enzymes in yields that allow industrial application on a large scale. Moreover, said engineered microorganisms can produce oxidases having improved properties with respect to their application in oxidation reactions and/or in bleaching and detergent products.
    Type: Grant
    Filed: September 24, 1990
    Date of Patent: August 31, 1993
    Assignee: Internationale Otrool Maatschappij "Octropa" B.V.
    Inventors: Adrianus M. Ledeboer, Jan Maat, Cornelis T. Verrips, Christiaan Visser, Zbigniew A. Janowicz, Cornelis P. Hollenberg
  • Patent number: 4859596
    Abstract: A new cloning system is described capable of expressing genetic material derived from recombinant DNA material, which comprises a yeast of the genus Kluyveromyces as a host. Suitable vectors are e.g. vectors containing autonomously replicating sequences (ARS) and vectors containing homologous Kluyveromyces DNA acting as a site for recombination with the host chromosome. New and preferred vectors are those containing ARS sequences originating from Kluyveromyces (KARS vectors). The genetically engineered new strains of Kluyveromyces produce, inter alia, lactase and chymosin.
    Type: Grant
    Filed: January 19, 1984
    Date of Patent: August 22, 1989
    Assignee: Gist-Brocades N.V.
    Inventors: Cornelis P. Hollenberg, Sunil Das, Albert De Leeuw, Johannes A. van den Berg